166 related articles for article (PubMed ID: 9214263)
1. Hepatitis C virus genotype, hepatitis C virus RNA titers, and response to interferon.
Taliani G; Badolato MC; Pasquazzi C
Ann Intern Med; 1997 Jul; 127(1):89. PubMed ID: 9214263
[No Abstract] [Full Text] [Related]
2. [Interferon therapy for acute hepatitis C: evaluation by HCV antibody, HCV genotypes and serum RNA titer].
Toyama H; Iwabuchi S
Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):521-7. PubMed ID: 7563813
[No Abstract] [Full Text] [Related]
3. Follow-up of hepatitis C virus RNA in peripheral blood mononuclear cells during interferon therapy.
Cribier B; Uhl G; Schmitt C; Doffoël M; Vetter D; Kirn A; Stoll-Keller F
Arch Virol; 1999; 144(2):355-64. PubMed ID: 10470259
[TBL] [Abstract][Full Text] [Related]
4. Treating patients with HCV genotype 1 and low viraemia: more than meets the eye.
Craxì A; Cammà C
J Hepatol; 2006 Jan; 44(1):4-7. PubMed ID: 16293337
[No Abstract] [Full Text] [Related]
5. The interferon sensitivity determining region: all hepatitis C virus isolates are not the same.
Herion D; Hoofnagle JH
Hepatology; 1997 Mar; 25(3):769-71. PubMed ID: 9049233
[No Abstract] [Full Text] [Related]
6. Predictive factors of virological non-response to interferon-ribavirin combination therapy for patients infected with hepatitis C virus of genotype 1b and high viral load.
Akuta N; Suzuki F; Sezaki H; Suzuki Y; Hosaka T; Someya T; Kobayashi M; Saitoh S; Watahiki S; Sato J; Kobayashi M; Arase Y; Ikeda K; Kumada H
J Med Virol; 2006 Jan; 78(1):83-90. PubMed ID: 16299715
[TBL] [Abstract][Full Text] [Related]
7. Management of hepatitis C virus genotype 4.
Abdo AA; Lee SS
J Gastroenterol Hepatol; 2004 Nov; 19(11):1233-9. PubMed ID: 15482528
[TBL] [Abstract][Full Text] [Related]
8. [Evaluating the efficacy of interferon therapy on hepatitis C patients].
Shiraha H; Iwasaki Y; Shiratori Y
Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):489-92. PubMed ID: 15359847
[No Abstract] [Full Text] [Related]
9. Regression of splenic lymphoma after treatment of hepatitis C virus infection.
Mazzaro C; Little D; Pozzato G
N Engl J Med; 2002 Dec; 347(26):2168-70; author reply 2168-70. PubMed ID: 12501232
[No Abstract] [Full Text] [Related]
10. Patterns of hepatitis C viremia in patients receiving hemodialysis.
Umlauft F; Gruenewald K; Weiss G; Kessler H; Urbanek M; Haun M; Santner B; Koenig P; Keeffe EB
Am J Gastroenterol; 1997 Jan; 92(1):73-8. PubMed ID: 8995941
[TBL] [Abstract][Full Text] [Related]
11. Effects of interferon treatment on liver histology and allograft rejection in patients with recurrent hepatitis C following liver transplantation.
Stravitz RT; Shiffman ML; Sanyal AJ; Luketic VA; Sterling RK; Heuman DM; Ashworth A; Mills AS; Contos M; Cotterell AH; Maluf D; Posner MP; Fisher RA
Liver Transpl; 2004 Jul; 10(7):850-8. PubMed ID: 15237368
[TBL] [Abstract][Full Text] [Related]
12. Influence of hepatitis G virus infection on the severity of liver disease and response to interferon-alpha in patients with chronic hepatitis C.
Martinot M; Marcellin P; Boyer N; Detmer J; Pouteau M; Castelnau C; Degott C; Aupérin A; Collins M; Kolberg J; Wilber J; Benhamou JP; Erlinger S
Ann Intern Med; 1997 Jun; 126(11):874-81. PubMed ID: 9163288
[TBL] [Abstract][Full Text] [Related]
13. [Current and future applications of viral clearance kinetics in the treatment of hepatitis C].
Buti M
Gastroenterol Hepatol; 2004 Feb; 27 Suppl 1():24-9. PubMed ID: 15195531
[No Abstract] [Full Text] [Related]
14. Hepatitis C virus core antigen: A simplified treatment monitoring tool, including for post-treatment relapse.
Lamoury FMJ; Soker A; Martinez D; Hajarizadeh B; Cunningham EB; Cunningham P; Bruggmann P; Foster GR; Dalgard O; Backmund M; Conway B; Robaeys G; Swan T; Cloherty G; Marks P; Grebely J; Dore GJ; Applegate TL
J Clin Virol; 2017 Jul; 92():32-38. PubMed ID: 28521211
[TBL] [Abstract][Full Text] [Related]
15. [HCV-RNA quantity of the serum].
Sasaki Y; Hige S; Nagasaka A; Matsushima T
Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):965-8. PubMed ID: 7563911
[No Abstract] [Full Text] [Related]
16. Prediction of relapse following treatment for hepatitis C: is whole blood more than the sum of its parts?
Shire N; Koziel MJ
Clin Infect Dis; 2004 Dec; 39(12):1761-3. PubMed ID: 15578396
[No Abstract] [Full Text] [Related]
17. [Diagnosis, treatment, and follow-up of hepatitis C-virus related liver disease. Hungarian national consensus guideline].
Hunyady B; Gervain J; Horváth G; Makara M; Pár A; Szalay F; Telegdy L; Tornai I
Orv Hetil; 2014 Mar; 155 Suppl():3-24. PubMed ID: 24631886
[TBL] [Abstract][Full Text] [Related]
18. [Comparison of hepatitis C viral RNA and core antigen kinetics in the therapeutic follow up of hepatitis C virus and human immunodeficiency virus co-infected patients, treated by bitherapy interferon-ribavirin, within the framework of RIBAVIC protocol].
Pivert A; Payan C; Lunel F;
Pathol Biol (Paris); 2004 Nov; 52(9):522-8. PubMed ID: 15531116
[TBL] [Abstract][Full Text] [Related]
19. Comparison of HCV RNA assays for the detection and quantification of hepatitis C virus RNA levels in serum of patients with chronic hepatitis C treated with interferon.
Trabaud MA; Bailly F; Si-Ahmed SN; Chevallier P; Sepetjan M; Colucci G; Trépo C
J Med Virol; 1997 May; 52(1):105-12. PubMed ID: 9131466
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis C virus type 1b (II) infection in France and Italy. Collaborative Study Group.
Nousbaum JB; Pol S; Nalpas B; Landais P; Berthelot P; Bréchot C
Ann Intern Med; 1995 Feb; 122(3):161-8. PubMed ID: 7810932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
